Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.05
+0.25 (3.68%)
Sep 14, 2026, 4:00 PM EDT - Market closed
Entrada Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 0.9 | 0.88 | 1.3 | 1.61 | 1.95 | 20.56 | 37.4 | 19.57 | 94.69 | 59.12 | 41.85 | 43.74 | 18.17 | 25.26 | - | - | - | - | - | - | |
Revenue Growth (YoY) | -53.95% | -95.74% | -96.53% | -91.75% | -97.94% | -65.23% | -10.63% | -55.25% | 421.16% | 134.05% | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue | 35.37 | 33.05 | 32.26 | 38.36 | 37.88 | 32.07 | 33.41 | 31.26 | 32.04 | 28.61 | 28.29 | 22.19 | 26.3 | 23.1 | 15.69 | 18.96 | 16.25 | 15.72 | 35.93 | - |
Gross Profit | -34.47 | -32.18 | -30.96 | -36.75 | -35.93 | -11.52 | 3.99 | -11.69 | 62.66 | 30.51 | 13.56 | 21.54 | -8.13 | 2.16 | -15.69 | -18.96 | -16.25 | -15.72 | -35.93 | - |
Selling, General & Admin | 10.49 | 10.12 | 9.35 | 10.3 | 10.92 | 10.27 | 9.86 | 9.97 | 9.24 | 9.4 | 8.65 | 7.53 | 8.17 | 7.94 | 9.89 | 6.98 | 7.33 | 6.43 | 6.1 | 3.85 |
Research & Development | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -23.56 | 10.51 |
Operating Expenses | 10.49 | 10.12 | 9.35 | 10.3 | 10.92 | 10.27 | 9.86 | 9.97 | 9.24 | 9.4 | 8.65 | 7.53 | 8.17 | 7.94 | 9.89 | 6.98 | 7.33 | 6.43 | -17.47 | 14.36 |
Operating Income | -44.96 | -42.3 | -40.31 | -47.05 | -46.85 | -21.79 | -5.87 | -21.66 | 53.42 | 21.11 | 4.91 | 14.01 | -16.3 | -5.78 | -25.58 | -25.94 | -23.58 | -22.15 | -18.46 | -14.36 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 |
Interest & Investment Income | 2.24 | 2.62 | 3.14 | 3.57 | 3.92 | 4.44 | 5.13 | 5.77 | 4.37 | 4.21 | 4.29 | 4.05 | 4.22 | 2.66 | 0.95 | 0.8 | 0.4 | 0.48 | 0.09 | - |
EBT Excluding Unusual Items | -42.73 | -39.68 | -37.17 | -43.48 | -42.93 | -17.35 | -0.74 | -15.89 | 57.79 | 25.33 | 9.2 | 18.06 | -12.08 | -3.12 | -24.63 | -25.14 | -23.18 | -21.67 | -18.37 | -14.43 |
Merger & Restructuring Charges | - | - | -1.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gain (Loss) on Sale of Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.07 | - |
Pretax Income | -42.73 | -39.68 | -39.07 | -43.48 | -42.93 | -17.35 | -0.74 | -15.89 | 57.79 | 25.33 | 9.2 | 18.06 | -12.08 | -3.12 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 |
Income Tax Expense | 0.04 | 0.04 | 0.09 | 0.65 | 0.18 | - | -1.87 | -1.86 | 2.76 | 1.83 | 18.74 | -17.4 | 13.85 | 3.55 | - | - | - | - | - | - |
Net Income | -42.76 | -39.72 | -39.16 | -44.13 | -43.1 | -17.35 | 1.13 | -14.03 | 55.03 | 23.5 | -9.54 | 35.46 | -25.93 | -6.67 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 |
Net Income to Common | -42.76 | -39.72 | -39.16 | -44.13 | -43.1 | -17.35 | 1.13 | -14.03 | 55.03 | 23.5 | -9.54 | 35.46 | -25.93 | -6.67 | -24.63 | -25.14 | -23.18 | -21.67 | -18.45 | -14.43 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 42 | 42 | 42 | 41 | 41 | 41 | 41 | 41 | 34 | 33 | 33 | 33 | 33 | 32 | 31 | 31 | 31 | 31 | 21 | 1 |
Shares Outstanding (Diluted) | 42 | 42 | 42 | 41 | 41 | 41 | 43 | 41 | 36 | 35 | 33 | 35 | 33 | 32 | 31 | 31 | 31 | 31 | 21 | 1 |
Shares Change (YoY) | 2.14% | 1.86% | -3.36% | 2.05% | 16.42% | 18.06% | 29.01% | 16.83% | 7.07% | 7.46% | 6.43% | 11.11% | 6.04% | 3.61% | 50.88% | 2021.66% | 2288.28% | 2386.85% | 1654.02% | 29.44% |
EPS (Basic) | -1.01 | -0.95 | -0.94 | -1.06 | -1.04 | -0.42 | 0.03 | -0.35 | 1.61 | 0.70 | -0.29 | 1.07 | -0.78 | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 | -0.89 | -9.78 |
EPS (Diluted) | -1.01 | -0.95 | -0.94 | -1.06 | -1.04 | -0.42 | 0.02 | -0.35 | 1.55 | 0.68 | -0.29 | 1.02 | -0.78 | -0.21 | -0.79 | -0.80 | -0.74 | -0.69 | -0.89 | -9.78 |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -32.47 | -41.74 | -32 | -28.14 | -29.76 | -39.65 | -32.24 | -24.91 | 38.79 | -26.36 | -4.99 | -25.94 | -36.61 | 201.73 | -28.01 | -28.29 | -18.78 | -21.59 | -21.86 | -14.88 |
Free Cash Flow Per Share | -0.77 | -1.00 | -0.77 | -0.68 | -0.72 | -0.96 | -0.75 | -0.61 | 1.09 | -0.76 | -0.15 | -0.75 | -1.10 | 6.23 | -0.89 | -0.90 | -0.60 | -0.69 | -1.05 | -10.09 |
Gross Margin | - | - | - | - | - | -56.02% | 10.67% | -59.72% | 66.17% | 51.61% | 32.40% | 49.26% | -44.74% | 8.54% | - | - | - | - | - | - |
Operating Margin | -5007.02% | -4834.63% | -3103.00% | -2915.18% | -2402.51% | -105.99% | -15.69% | -110.67% | 56.42% | 35.71% | 11.72% | 32.04% | -89.70% | -22.88% | - | - | - | - | - | - |
Profit Margin | -4762.03% | -4539.09% | -3014.93% | -2734.45% | -2210.41% | -84.39% | 3.02% | -71.70% | 58.12% | 39.74% | -22.81% | 81.08% | -142.70% | -26.42% | - | - | - | - | - | - |
Free Cash Flow Margin | -3616.26% | -4770.17% | -2463.13% | -1743.62% | -1526.36% | -192.87% | -86.21% | -127.26% | 40.96% | -44.58% | -11.92% | -59.31% | -201.50% | 798.62% | - | - | - | - | - | - |
EBITDA | -44.12 | -41.5 | -39.42 | -45.82 | -45.82 | -20.84 | -4.88 | -20.72 | 54.33 | 22.05 | 5.64 | 14.85 | -15.57 | -5.24 | -25.05 | -25.42 | -23.12 | -21.76 | -18.1 | -14.06 |
EBITDA Margin | - | - | - | - | - | -101.39% | -13.04% | -105.88% | 57.38% | 37.29% | 13.48% | 33.95% | -85.69% | -20.74% | - | - | - | - | - | - |
D&A For EBITDA | 0.84 | 0.81 | 0.89 | 1.23 | 1.03 | 0.95 | 0.99 | 0.94 | 0.91 | 0.93 | 0.74 | 0.83 | 0.73 | 0.54 | 0.53 | 0.52 | 0.46 | 0.39 | 0.36 | 0.3 |
EBIT | -44.96 | -42.3 | -40.31 | -47.05 | -46.85 | -21.79 | -5.87 | -21.66 | 53.42 | 21.11 | 4.91 | 14.01 | -16.3 | -5.78 | -25.58 | -25.94 | -23.58 | -22.15 | -18.46 | -14.36 |
EBIT Margin | - | - | - | - | - | -105.99% | -15.69% | -110.67% | 56.42% | 35.71% | 11.72% | 32.04% | -89.70% | -22.88% | - | - | - | - | - | - |
Effective Tax Rate | - | - | - | - | - | - | - | - | 4.77% | 7.23% | 203.77% | - | - | - | - | - | - | - | - | - |